WhaleCreepWhat the best hedge funds own, from their SEC 13F filings
HomeFundsBrave Warrior Advisors › Q2 2013

Brave Warrior Advisors 13F holdings, Q2 2013

Holdings as of June 30, 2013 · filings on SEC EDGAR · latest filing →

Brave Warrior Advisors disclosed 11 US equity positions worth $2.2bn in its Q2 2013 13F filing. The largest position was VALEANT PHARMACEUTICALS INTL at 26.5% of the reported book, followed by VISTAPRINT N V and EXPRESS SCRIPTS HLDG CO. Against the Q1 2013 filing, it opened 9 new positions, added to 2 and reduced 0 among the top 11 holdings.

← Q1 2013 · Q3 2013 →

What did Brave Warrior Advisors own in Q2 2013? Top 11 positions

#StockSectorWeightValueSharesΔ sharesvs Q1 2013
1 VALEANT PHARMACEUTICALS INTL 26.5%$573.1m6,657,451 new
2 VISTAPRINT N V 13.1%$283.9m5,750,690 new
3 EXPRESS SCRIPTS HLDG CO 12.0%$259.0m4,194,400 new
4 SCHW SCHWAB CHARLES CORP NEW Financial Services 9.2%$198.8m9,363,034 7% added
5 ORCL ORACLE CORP Technology 8.7%$187.8m6,115,172 new
6 HAL HALLIBURTON CO Energy 8.5%$183.4m4,394,875 190% added
7 PRI PRIMERICA INC Financial Services 5.8%$124.9m3,335,976 new
8 COMCAST CORP NEW 5.1%$109.5m2,759,871 new
9 FISV FISERV INC 4.5%$98.1m1,122,181 new
10 HIGHER ONE HLDGS INC 3.4%$73.6m6,319,325 new
11 GOOGLE INC 3.1%$67.8m77,016 new

Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.